African Nodding Syndrome Disease May be Spread by Blackflies
Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected with the parasite Onchocerca volvulus may be capable of passing on a secondary pathogen that is to blame for the spread of the disease. New research is presented in the International Journal of Infectious Diseases. (Source: Disabled World)
Source: Disabled World - October 6, 2014 Category: Disability Tags: Africa Source Type: news
Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
applauds the government of Ecuador on being the second country in the
world to receive World Health Organization (WHO) verification of the
elimination of river blindness (onchocerciasis) using MECTIZAN®
(ivermectin).
Language:
English
Contact:
MerckJen...
Source: Merck.com - Corporate News - October 3, 2014 Category: Pharmaceuticals Tags: Corporate News Corporate Responsibility News Latest News Source Type: news
Blackflies may be responsible for spreading nodding syndrome
Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected with the parasite Onchocerca volvulus may be capable of passing on a secondary pathogen that is to blame for the spread of the disease. When present, the first indication of the disease is an involuntary nodding of the head, followed by epileptic seizures. The condition can cause cognitive deterioration, stunted growth, and in some cases, death. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 2, 2014 Category: Science Source Type: news
Blackflies may be responsible for spreading nodding syndrome
(Elsevier Health Sciences) Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome, a disabling disease affecting African children. A new report suggests that blackflies infected with the parasite Onchocerca volvulus may be capable of passing on a secondary pathogen that is to blame for the spread of the disease. New research is presented in the International Journal of Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 2, 2014 Category: Infectious Diseases Source Type: news
Ghana: Neglected Tropical Diseases Causing Havoc in Ghana
[Ghanaian Chronicle]About 12 million people living in 98 districts in Ghana stand the risk of contracting lymphatic filariasis (elephantiasis). Four million others, from 63 districts are also at risk of being infected with onchocerciasis (river blindness), according to the Ministry of Health. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 18, 2014 Category: African Health Source Type: news
Cameroon: Cameroon to Strengthen River Blindness Prevention
[Cameroon Tribune]The Director of Africa's Onchocerciasis Control Progamme was at the Ministry of Public Health on April 29, 2014. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 6, 2014 Category: African Health Source Type: news
Nigeria: NTDs - Attention Heightens for Elephantiasis, River Blindness, 8 Others
[Vanguard]THEy are 10 in number - all physiologically complex and pathologically dangerous vector-borne diseases. The mode of their action is diabolical. The menace of their effect on health and wellbeing is debasing. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 22, 2014 Category: African Health Source Type: news
Africa: Carter Center Marks Progress in Fight Against Guinea Worm, River Blindness
[VOA]Chicago -Guinea worm disease and river blindness are among 17 tropical diseases the World Health Organization considers neglected. Thanks to the efforts of the Atlanta-based Carter Center - founded by former president Jimmy Carter and his wife Rosalynn - focused treatment and prevention are leading to the elimination of one, and the extinction of another. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 7, 2014 Category: African Health Source Type: news
Weak spot of parasitic worms attacked to cure tropical diseases
(University of Liverpool) Researchers are developing new drug treatments to tackle river blindness and elephantiasis, which affect up to 150 million people across the world. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 20, 2014 Category: Biology Source Type: news
LSTM-Eisai-UoL awarded GHIT Fund to deliver anti-Wolbachia drug discovery
(Liverpool School of Tropical Medicine) The Liverpool School of Tropical Medicine together with colleagues at the Department of Chemistry (University of Liverpool) and Japanese pharmaceutical company Eisai are pleased to announce that they have been award a Global Health Innovative Technology Fund to develop new drugs to target lymphatic filariasis and onchocerciasis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2014 Category: Global & Universal Source Type: news
River blindness: 'you never sleep'
The machete blades turned red with heat in the fire that the rubber workers built on a Liberia plantation, Thomas Unnasch remembers from a visit in the 1980s. (Source: CNN.com - Health)
Source: CNN.com - Health - March 19, 2014 Category: Consumer Health News Source Type: news
According to the WHO, Neglected Tropical Diseases (NTDs) affect over 1 billion people worldwide, and are devastating to patients in the developing world. What is being done to get treatments to these patients and to speed development of new treatments?
conversationsneglected tropical diseasestropical diseasesnew medicinesInnovationOpinion46864687468846894690469246914693Neglected Tropical Diseases (NTDs) impact more than a billion people in some of the poorest, most remote parts of the world, blinding, disabling, disfiguring and sickening those infected. They have a negative impact on life expectancy, productivity and childhood education -- all of which create a cycle of poverty and stigma for affected communities.
Today, because of renewed and new commitments, millions impacted by NTDs are being treated, several NTDs are being controlled effectively, and some even elimin...
Source: PHRMA - December 10, 2013 Category: Pharmaceuticals Authors: Stephen Source Type: news
[Press Release] Deadly Gaps Persist in New Drug Development for Neglected Diseases
This study reports a slight increase of 2.4 new products/year for 2000-2011 and predicts 4.7 new products/year through 2018.
"Although strides have been made in the last decade, we still see deadly gaps in new medicines for some of the world's least visible patients," said Dr. Nathalie Strub-Wourgaft, medical director of DNDi. "We need to get more treatment candidates, NCEs or existing ones for repurposing, into and through the R&D pipeline to fundamentally change the way we manage these diseases."
"Our patients are still waiting for true medical breakthroughs," said D...
Source: MSF News - December 3, 2013 Category: Global & Universal Source Type: news
Pharma Technology Focus - Issue 25
In this issue we look at the personalised medicine revolution, investigate the tireless work on the elimination of malaria, catch up with a campaign to eliminate river blindness and much more (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 24, 2013 Category: Pharmaceuticals Source Type: news
Deadly Gaps Persist in New Drug Development for Neglected Diseases
This study reports a slight increase of 2.4 new products/year for 2000-2011 and predicts 4.7 new products/year through 2018.
"Although strides have been made in the last decade, we still see deadly gaps in new medicines for some of the world's least visible patients," said Dr. Nathalie Strub-Wourgaft, medical director of DNDi. "We need to get more treatment candidates, NCEs or existing ones for repurposing, into and through the R&D pipeline to fundamentally change the way we manage these diseases."
"Our patients are still waiting for true medical breakthroughs," said D...
Source: MSF News - October 24, 2013 Category: Global & Universal Source Type: news
